Women and Fosamax

Recent studies have shown that women are more at risk of fractures in the thigh bone, especially those who have used Fosamax for a long time. Short-term use of bisphosphonates does help in bone density by slowing the resorption of the bone; however there long-term use can actually hinder new bone formations, decreasing the bones ability to fix microscopic cracks caused by everyday wear and tear. As time passes, these microscopic cracks can then be the cause of a fracture. What also makes Fosamax dangerous is the mineralization of the bone while the breakdown process is happening, causing a “hypermineralized” bone that may be fragile and not strong enough for erosion. This can cause women to become more in danger of having a serious bone fracture.

Based on a statement made by Merk, the manufacturer of Fosamax, studies are to be made in order to guarantee the safety and effectiveness of their product without causing major side effects to their patients. The FDA has also issued warnings about the dangers of long-term use of Fosamax, along with other bisphosphonates, particularly for women who are using them as medication for osteoporosis.

Although further studies are still needed to fully determine the risks and complications that come with using Fosamax, many doctors still advice their patients to not stop their medications, and report any symptoms of side effects such as nausea, vomiting, problems swallowing, fever, blisters on the skin, painful or swollen gums, loose teeth, pain in the eyes, facial swelling, chest pain, or worsening or new heartburns. Feeling pain in the hip or thigh bones are indicative of possible bone fractures, therefore having regular check-ups with your doctor regarding bone density and health is highly recommended.

Along with taking Fosamax for osteoporosis, proper diet and exercise are also urged to support bone growth and health. Ask your doctor the proper foods and drinks to take, along with possible supplements to ensure that you are kept in proper physical condition.